This document discusses the clinical approach to evaluating patients presenting with palpitations. It defines palpitations and describes the physiology and common causes. Cardiac causes account for 43% of cases, while psychiatric conditions cause 31%. The document outlines the diagnostic evaluation including history, physical exam, ECG and ambulatory monitoring. It provides guidance on when to refer to cardiology or admit to the hospital. The management focuses on reassurance, lifestyle changes, treating underlying conditions, anxiolytics, beta-blockers, antiarrhythmics or cardioversion depending on the severity and nature of the arrhythmia.
AV nodal reentrant tachycardia (AVNRT), or atrioventricular nodal reentrant tachycardia, is a type of tachycardia (fast rhythm) of the heart. It is a type of supraventricular tachycardia (SVT), meaning that it originates from a location within the heart above the bundle of His. AV nodal reentrant tachycardia is the most common regular supraventricular tachycardia. It is more common in women than men (approximately 75% of cases occur in females). The main symptom is palpitations. Treatment may be with specific physical maneuvers, medication, or, rarely, synchronized cardioversion. Frequent attacks may require radiofrequency ablation, in which the abnormally conducting tissue in the heart is destroyed.
AVNRT occurs when a reentry circuit forms within or just next to the atrioventricular node. The circuit usually involves two anatomical pathways: the fast pathway and the slow pathway, which are both in the right atrium. The slow pathway (which is usually targeted for ablation) is located inferior and slightly posterior to the AV node, often following the anterior margin of the coronary sinus. The fast pathway is usually located just superior and posterior to the AV node. These pathways are formed from tissue that behaves very much like the AV node, and some authors regard them as part of the AV node.
The fast and slow pathways should not be confused with the accessory pathways that give rise to Wolff-Parkinson-White syndrome (WPW syndrome) or atrioventricular reciprocating tachycardia (AVRT). In AVNRT, the fast and slow pathways are located within the right atrium close to or within the AV node and exhibit electrophysiologic properties similar to AV nodal tissue. Accessory pathways that give rise to WPW syndrome and AVRT are located in the atrioventricular valvular rings. They provide a direct connection between the atria and ventricles, and have electrophysiologic properties similar to ventricular myocardium.
AV nodal reentrant tachycardia (AVNRT), or atrioventricular nodal reentrant tachycardia, is a type of tachycardia (fast rhythm) of the heart. It is a type of supraventricular tachycardia (SVT), meaning that it originates from a location within the heart above the bundle of His. AV nodal reentrant tachycardia is the most common regular supraventricular tachycardia. It is more common in women than men (approximately 75% of cases occur in females). The main symptom is palpitations. Treatment may be with specific physical maneuvers, medication, or, rarely, synchronized cardioversion. Frequent attacks may require radiofrequency ablation, in which the abnormally conducting tissue in the heart is destroyed.
AVNRT occurs when a reentry circuit forms within or just next to the atrioventricular node. The circuit usually involves two anatomical pathways: the fast pathway and the slow pathway, which are both in the right atrium. The slow pathway (which is usually targeted for ablation) is located inferior and slightly posterior to the AV node, often following the anterior margin of the coronary sinus. The fast pathway is usually located just superior and posterior to the AV node. These pathways are formed from tissue that behaves very much like the AV node, and some authors regard them as part of the AV node.
The fast and slow pathways should not be confused with the accessory pathways that give rise to Wolff-Parkinson-White syndrome (WPW syndrome) or atrioventricular reciprocating tachycardia (AVRT). In AVNRT, the fast and slow pathways are located within the right atrium close to or within the AV node and exhibit electrophysiologic properties similar to AV nodal tissue. Accessory pathways that give rise to WPW syndrome and AVRT are located in the atrioventricular valvular rings. They provide a direct connection between the atria and ventricles, and have electrophysiologic properties similar to ventricular myocardium.
The rhythm is best analyzed by looking at a rhythm strip.
On a 12 lead ECG this is usually a 10 second recording from Lead II.
Confirm or corroborate any findings in this lead by checking the other leads.
A longer rhythm strip, recorded perhaps recorded at a slower speed, may be helpful.
syncope in children , vasovagal syncope , fainting in children , causes of syncope in children , how to manage syncope in children , cardiac syncope , differnetial diagnosis of syncope , approach to syncope
Fainting: Causes and Ways to Minimize RiskSummit Health
Fainting may cause physical injury, lead to hospitalization and be a sign of an underlying cardiac disorder. Our cardiac electrophysiologist will review the causes of fainting, tell who's at risk, and discuss methods to minimize the chances of fainting. Presentation by Summit Medical Group Cardiologist Roy Sauberman, MD FACC
Ramadan fasting is ritual for all muslims worldwide , where there is abstinace from eating , drinking and smoking from dawn to dusk , daily for one month, frequently , hypertensives asking about their fasting and medications during Ramadan, in the lecture , some focus on the effect of Ramadan on blood pressure , heart rate and other cardiovascular risk factors and lastly general instruction for hypertensives during Ramadan .
Antiplatelet therapy there is a gap between guidelines and implementationA.Salam Sharif
platelets play an important role in cardiovascular diseases, the final event leading to ACS is a spontaneous atherosclerotic plaques which initiates a platelet response with platelet adhesion to vascular wall with activation and agregation and finally clot formation with clinical sequences od CV deaths, MI and myocardial ischemia and arrhythmias, so atiplatelet therapy is crucial in treatment of ACS, in the topic I review the traditional agents and new agents , focusing on guidelines and real world of their cinical uses .
ECG is very important tool in diagnosis of various cardiovascular diseases ,it is important for every one dealing with cardiac patients to be aware about the basic information of electocardiogram, so my 2nd lecture focused on measurements abnormalities, abnormalities of rhythm, and conduction and various cardiac chamber abnormalities of ST-segment and T-waves .
ECG is very important tool in diagnosis of various cardiovascular diseases ,it is important for every one dealing with cardiac patients to be aware about the basic information of electocardiogram, so my 1st lecture focused on conductiong system of the heart , the generation of deflection in ECG , and normal morphology of its waveform, and lastly focus oh method to determine heart rate and cadiac axis .
Early statin therapy in Acute myocardial Infarction with low LDL- cholestrolA.Salam Sharif
Effect of statin therapy on dyslipidemia is well known, and the beneficial efficacy of statin therapy in primary and secondary prevention of cardiovascular events was docmented in a lot of RCTs. Mant studies recomended the statin therapy earlier in ACS, and what about the effect of statin in situation of AMI patients with low LDL- cholestrol.
Microalbuminuria in diabetic and hypertensive patient2A.Salam Sharif
microalbuminuria is early sign of general vasculopathy and hurbinger of ESRD, the significance of microalbuminuria in diabetic and hypertensive patients is risky sign for further cardiovascular diseases, in this discussion I aimed to discuss the therapeutic approach for these patients
The role of antiplatelets in preventing and reducing the incidence of cardiovascular diseases, the usage of these agents in elderly patients is not well known, the presenetation discuss this issue
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
3. Uncomfortable awareness of heart beat or undue awareness of heart action.
Defined as thumping , pounding or fluttering sensation in the chest.
This sensation can be either intermittent or sustained and either regular or irregular
Definition
4. Physiology
Palpitation is due to
Alteration in heart rate
Eg: sinus tachycardia & bradycardia
Alteration in heart rhythm
Eg: Atrial fibrillation
Augmentation of myocardial contraction
Eg: anxiety states & drugs
7. Independent Predictors of Cardiac Etiology of
Palpitation
Male sex
Description of an irregular heart beat
History of heart disease
Event duration >5 minutes
1 predictor : 26%
2 predictors: 48%
3 predictors: 71%
8. Psychiatric Causes
Panic attacks
Anxiety states
Somatization
Depression
Patients with psychiatric causes for palpitations more commonly report a longer duration of sensation
>15min, younger & disabled & multiplicity of symptoms than do patients with other causes with more
visits to ER .
10. Continued
Spontaneous skeletal muscle contractions of the chest wall
Systemic mastocytosis
Physiological : exertion , excitement , pregnancy
Neurocirculatory asthenia or Da costa’s syndrome or Effort syndrome or Soldier’s
heart
Vaso-vagal attack
11. Why to evaluate and treat arrhythmias
Eliminate symptoms.
Prevent imminent death and hemodynamic collapse due to a life-threatening
arrhythmia.
Reduce possible risks other than the direct effects of the arrhythmia (eg, reduce
stroke in patients with atrial fibrillation).
12. On facing a patient with palpitation for 1st time
Is the arrhythmia causing symptoms or could it?
Does the arrhythmia pose a risk to the patient?
Which arrhythmia is present?
Does the arrhythmia require emergent cardioversion?
Does the patient require urgent hospitalization?
Is specialist consultation required, and if so, how urgently?
Should anticoagulation and/or other medical therapy be started?
13.
14. Diagnostic Evaluation
1. History
I. Age of onset
II. Description ( rate , degree of regularity of palpitation)
* rapid and regular —> SVT & VT
* rapid and irregular —> AF , A.flutter or tachycardia with variable block.
* Flip- flopping —>atrial or ventricular PBs.
* rapid fluttering —>sustained VT or SVT
regular : AVNRT , irregular : AF
* pounding in neck —> AV dissociation as in PVC, CHB or VT
rapid and regular pounding in neck ( frog sign ) : SVNRT.
III. Onset and offset
* randomly and episodically and last for an instant : mostly premature beats
* abrupt onset and offset : SVT or VT
* gradual onset and offset : sinus tachycardia
* mode of termination :vagal stimulation —> SVT
15. Continued
IV. Positional palpitation
* palpitation upon standing up straight after bending over and end by lying down : mostly AVNRT.
* intermittent pounding sensation on lying in bed —>atrial or VPBs
V. Palpitation associated with other symptoms.
VI. Palpitations of psychiatric causes :
* younger and disabled patients.
* more somatization.
* palpitations duration > 15 minutes
* accompanied by more ancillary symptoms
* more visits to ER
VI. Medications and habits
17. How To Evaluate Palpitation
Step 1
Is palpitation continuous or intermittent ?
Intermittent P. are commonly caused by premature atrial or ventricular
contractions : the post extrasystolic beat is sensed by the patient owing to the
increase in ventricular end-diastolic dimension following the pause in the cardiac
cycle and the increased strength of contraction (post-extrasystolic potentiation)
18. Step 2
Is heart beat regular or irregular ?
Regular , sustained palpitations can be caused by SVT and VT
Irregular , sustained palpitations can be caused by Atrial fibrillation
19. Step 3
What is the ~ heart rate ?
Step 4
Does palpitations occur in discrete attacks ?
Is onset abrupt?
How do attacks terminate?
-Ventricular arrhythmias are of sudden onset
-Holding breath or vagal maneuvers decrease palpitations in SVT
20. Step 5
Are there any associated symptoms ?
Chest pain : Arrhythmogenic MI
Dyspnea : Heart failure due to arrhythmias
Syncope : low cardiac output during arrhythmias , hypoglycemia , pheochromocytoma
Polyuria : SVT
Sweating : Anxiety ,hypoglycemia
Diarrhoea : Thyrotoxicosis
21. Step 6
Are there any precipitating factors ?
exercise , stress ( hyperdynamic cardiovascular states caused by catecholaminergic stimulation)
alcohol intake , drugs, Palpitations that are positional, generally reflect a structural process
within heart
e.g. : Atrial myxoma
or adjacent to the heart
e.g. : Mediastinal mass
Step 7
Is there a history of structural heart disease ?
Coronary HD , valvular HD, Cardiomyopathies
22. “It is often useful either to ask the patient to tap out the rhythm
of the palpitations or to take his / her pulse while experiencing
palpitations”
23. Nature Of Palpitation
Feature Suggests
HEART MISSES AND THUMPS ECTOPIC BEATS
WORSE AT REST ECTOPIC BEATS
VERY FAST REGULAR SVT / VT
SUDDEN ONSET SVT / VT
OFFSET WITH VAGAL MANOEUVRES SVT
FAST AND IRREGULAR AF and ATRIAL FLUTTER with varying block
FORCEFUL AND REGULAR – NOT FAST AWARENESS OF SINUS RHYTHM (ANXIETY)
SEVERE DIZZINESS OR SYNCOPE VT or BRADYARRHYTHMIAS
PRE-EXISTING HEART FAILURE VT
24. Simple Approach To Diagnosis Of Palpitation
Is heart beat
regular ?
YES
Are there any discrete attacks of
tachycardia >120/min
YES
SVT
VT
NO
Sinus tachycardia
High stroke volume
NO
Irregular heart beat
Ectopic beats
AF
25.
26. 2. Physical examination
Key features of physical examination that will help confirm the presence of
arrhythmia as a cause for the palpitations include
Measurement of vital signs
Assessment of the jugular venous pressure and pulse
Auscultation of the chest and precordium
27. 3. Investigations
A resting ECG
If exertion is known to induce arrhythmia and accompanying palpitations ,
exercise ECG is useful
2D-ECHO
When patients complaining of palpitations undergo 24-hour, ambulatory ECG
monitoring, 39 to 85 percent manifest a rhythm disturbance (most being benign and
clinically insignificant).
28. Continued
If arrhythmia is sufficiently infrequent , other methods must be used like
Continuous ECG ( Holter ) monitoring ,
Trans telephonic monitoring ,
Loop recordings (external or implantable) &
Mobile cardiac outpatient telemetry.
Event recorder
29. Further Diagnostic Testing
Diagnostic testing is recommended for three groups of patients:
Those in whom the initial diagnostic evaluation (history, physical examination, and
electrocardiogram) suggests an arrhythmic cause. Testing is particularly important in
patients who experience syncope or presyncope in association with palpitations.
Those who are at high risk for an arrhythmia. Patients are considered at high risk
if they have organic heart disease or any myocardial abnormality that can lead to serious
arrhythmias, including scar formation from myocardial infarction, idiopathic dilated cardiomyopathy,
clinically significant valvular regurgitant or stenotic lesions, and hypertrophic cardiomyopathy. These
disorders have all been shown to be associated with the development of ventricular tachycardia .
Other high-risk patients are those with a family history of arrhythmia, syncope, or sudden death
from cardiac causes, such as from a cardiomyopathy or the long QT syndrome. Low-risk patients are
those without a potential substrate for arrhythmias.
Those who remain anxious to have a specific explanation for their
symptoms.
30. Outpatient Monitoring Systems
Traditional Holter-continuous recording of 24 or 48 hours.
Event recorder-patient activated recorder, either looping or non looping. Some newer models have
automatic arrhythmia detection software to store asymptomatic episodes. Data is transmitted over
the phone to a monitoring station.
Mobile continuous outpatient cardiac telemetry-continuous recording and analysis, with
symptomatic or algorithm defined episodes transmitted automatically via cellular technology to
monitoring station.
Implantable loop recorder-patient and algorithm defined episodes stored in device, until
interrogated either in office or remotely via home equipment and internet.
The 1999 American College of Cardiology/American Heart Association (ACC/AHA) guidelines on
ambulatory electrocardiography concluded that there were two main indications for ambulatory
monitoring in the assessment of arrhythmia.
(1) the assessment of unexplained syncope, near syncope, or episodic dizziness
(2) the assessment of unexplained recurrent palpitations
31. Diagnostic Recommendations For Palpitation
* No evidence of HD
*Tolerated and
unsustained
• 1. Reassurance
• 2. Ambulatory
monitoring , better 2
weeks trans telephonic
monitoring
* Evidence of HD
* Unsustained
• Ambulatory Monitoring
* Sustained
*Poorly tolerated
With or without HD
• EPS with or without
prior ambulatory
monitoring
35. Recent data suggests Holter monitoring is of limited clinical utility while
implantable loop recorder and mobile cardiac outpatient telemetry are
safe and more cost effective in assessment of patients with recurrent ,
unexplained palpitations
36.
37. Referral to Cardiologist
Any patient with an arrhythmia when the primary care physician is uncomfortable
with either diagnosis or management
Candidates for permanent pacing
Those with an uncertain diagnosis, prognosis, or management strategy
Those who might benefit from implantation of an implantable Cardioverter
Defibrillator or biventricular pacemaker
Those who might benefit from a catheter ablation procedure
Those who might benefit from antiarrhythmic drug therapy
38. Decision for Hospitalization
The presence and severity of structural heart disease.
The indication for treatment (eg, etiology of the arrhythmia and type and severity
of associated symptoms). Treatment for ventricular tachycardia is usually started in
the hospital.
The drug used. For example, the labeling information
for dofetilide and sotalol specify inpatient initiation,
while flecainide , propafenone ,dronedarone , and amiodarone can generally be
initiated outside the hospital in appropriate patients.
39. Management
in a Nutshell
• Re-assurance
• Lifestyle modification
• Correction of co-morbid diseases
• Anxiolytics and Beta-blockers
• Anti-arrhythmic drugs / electrical conversion
Recurrent life-threatening
ventricular arrhythmias are currently
being treated with Implantable
Cardioverter-Defibrillitor devices